SCHEMBL16112616

SCHEMBL16112616

Cc1cn2nc(-c3ncc(Cc4ccc(F)cc4)s3)cc2c(-c2cc(F)c3c(c2C)CCCO3)c1C(OC(C)(C)C)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 2/20 0.48
KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16112613 1.00 NR1I2 (0.48) NR1I2KCNH2
SCHEMBL16113895 0.89 NR1I2 (0.48) NR1I2KCNH2
SCHEMBL16112848 0.89 NR1I2 (0.48) NR1I2KCNH2
SCHEMBL16112830 0.84 NR1I2 (0.47) NR1I2KCNH2
SCHEMBL16148449 0.84 NR1I2 (0.71) NR1I2KCNH2
SCHEMBL16113746 0.82 CYP3A4 (0.51) NR1I2KCNH2
SCHEMBL16112483 0.81 CYP3A4 (0.33) NR1I2KCNH2
SCHEMBL16113333 0.79 NR1I2 (0.61) NR1I2
SCHEMBL16112770 0.79 KCNH2 (0.48) NR1I2KCNH2
SCHEMBL16113135 0.79 KCNH2 (0.48) NR1I2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970274-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION Bristol-Myers Squibb Company (US) 2016-01-20 EP disclosed
WO-2014159959-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BRISTOL-MYERS SQUIBB COMPANY (US) 2014-10-02 WO disclosed